Compounds > naltrexone

naltrexone and Mydriasis

naltrexone has been researched along with Mydriasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bell, RL; Gonzales, CR; Hart, JC; Lowe, SL; McKinzie, DL; McKinzie, JH; Mitch, CH; Need, AB; Rorick-Kehn, LM; Statnick, MA; Stoltz, RR; Suico, JG; Tauscher-Wisniewski, S; Weller, MA; Witcher, JW; Wong, CJ1
Sharpe, LG1

Trials

1 trial(s) available for naltrexone and Mydriasis

ArticleYear
Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human.
    The international journal of neuropsychopharmacology, 2014, Oct-31, Volume: 18, Issue:2

    Topics: Adolescent; Adult; Animals; Benzamides; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Fentanyl; Humans; Male; Middle Aged; Miosis; Morphine; Mydriasis; Naltrexone; Narcotic Antagonists; Narcotics; Pupil; Pyrrolidines; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Young Adult

2014

Other Studies

1 other study(ies) available for naltrexone and Mydriasis

ArticleYear
Separate neural mechanisms mediate sufentanil-induced pupillary responses in the cat.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 256, Issue:3

    Topics: Analgesics, Opioid; Animals; Cats; Clonidine; Drug Interactions; Fentanyl; Male; Morphine; Mydriasis; Naltrexone; Pupil; Receptors, Opioid; Receptors, Opioid, mu; Sufentanil

1991